HLB Pharmaceutical Co., Ltd (047920.KQ)
KRW 19740.0
(3.13%)
KRW 19740.0
(3.13%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.85 Billion KRW | 18.83% |
| 2022 | 17.55 Billion KRW | 42.15% |
| 2021 | 12.34 Billion KRW | 74.92% |
| 2020 | 7.05 Billion KRW | 24.99% |
| 2019 | 5.64 Billion KRW | 4.94% |
| 2018 | 5.38 Billion KRW | 10.2% |
| 2017 | 4.88 Billion KRW | 72.89% |
| 2016 | 2.82 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 20.62 Billion KRW | -4.59% |
| 2024 Q1 | 21.61 Billion KRW | 3.65% |
| 2023 Q2 | 21.72 Billion KRW | 8.82% |
| 2023 Q4 | 20.85 Billion KRW | 1.67% |
| 2023 Q3 | 20.51 Billion KRW | -5.56% |
| 2023 FY | 20.85 Billion KRW | 18.83% |
| 2023 Q1 | 19.96 Billion KRW | 13.72% |
| 2022 Q2 | 12.96 Billion KRW | -0.84% |
| 2022 Q4 | 17.55 Billion KRW | 7.86% |
| 2022 Q1 | 13.07 Billion KRW | 5.87% |
| 2022 Q3 | 16.27 Billion KRW | 25.55% |
| 2021 Q4 | 12.34 Billion KRW | 6.79% |
| 2021 Q3 | 11.56 Billion KRW | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| CMG Pharmaceutical Co., Ltd. | 15.87 Billion KRW | -31.383% |
| Celltrion Pharm, Inc. | 100.42 Billion KRW | 79.229% |
| Huons Global Co., Ltd. | 121.81 Billion KRW | 82.878% |
| DongKook Pharmaceutical Co., Ltd. | 138.34 Billion KRW | 84.923% |
| Enzychem Lifesciences Corporation | 14.94 Billion KRW | -39.558% |
| Humedix Co., Ltd. | 28.62 Billion KRW | 27.134% |
| Boditech Med Inc. | 31.6 Billion KRW | 34.0% |
| EuBiologics Co., Ltd. | 13.34 Billion KRW | -56.34% |
| FutureChem Co.,Ltd | 1.37 Billion KRW | -1417.499% |
| Huons Co., Ltd. | 76.59 Billion KRW | 72.769% |
| BNC Korea Co., Ltd. | 11.39 Billion KRW | -83.071% |
| AptaBio Therapeutics Inc. | - KRW | -Infinity% |